Table 3.
Associations between Patient Characteristics and EGFR and KRAS Mutations
| EGFR Mutation Status | |||||
|---|---|---|---|---|---|
| Variable | Positive | Negative | t test P value | ||
| # | Mean ± SE | # | Mean ± SE | ||
| Age | 60 | 65.1 ± 1.4 | 303 | 62.9 ± 0.7 | 0.18 |
| Charlson Comorbidity Index | 60 | 5.1 ± 0.3 | 303 | 5.9 ± 0.1 | 0.002 |
| Age-weighted Comorbidity Index | 60 | 7.1 ± 0.3 | 303 | 7.9 ± 0.1 | 0.02 |
| KRAS Mutation Status | |||||
|---|---|---|---|---|---|
| Variable | Mutant | Wild Type | t test P value | ||
| # | Mean ± SE | # | Mean ± SE | ||
| Age | 83 | 62.3 ± 1.1 | 207 | 62.6 ± 0.9 | 0.82 |
| Charlson Comorbidity Index | 83 | 6.0 ± 0.2 | 206 | 5.8 ± 0.1 | 0.31 |
| Age-weighted Comorbidity Index | 83 | 7.9 ± 0.2 | 206 | 7.7 ± 0.2 | 0.46 |